Skip to search formSkip to main contentSkip to account menu

Sabril

Known as: Sabrilex 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Vigabatrin
Vigabatrin 500 MG Oral Tablet [Sabril]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Babies with microcephaly in Brazil are struggling to access care
One year after the Brazilian Ministry of Health declared a public health emergency because of the large rise in the number of… 
2014
2014
Localisation cérébrale d’une hémangiomatose diffuse néonatale
2014
2014
Vigabatrin-associated visual field loss: past, present and future
Although a highly effective medication for treatment of infantile spasms and refractory complex partial seizures, vigabatrin (VGB… 
Review
2010
Review
2010
ACS chemical neuroscience molecule spotlight on Sabril.
Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages… 
Review
2007
Review
2007
[Epilepsy and Sabril].
This article presents a litterature overview of the ophthalmologic secondary effects due to Sabril. First, a review of the visual… 
2004
2004
Conduite du traitement par les antiépileptiques au long cours dans les épilepsies partielles pharmacorésistantes de l’adulte
Review
2003
Review
2003
[New epileptic treatments. Current modalities and their utilization].
  • P. Thomas
  • Presse medicale
  • 2003
  • Corpus ID: 23155026
NINE NEW MOLECULES: Since 1990, nine antiepileptic drugs have been launched in France: vigabatrin (Sabril), felbamate (Taloxa… 
2002
2002
A comparative study between Sabril (Vigabatrin) and ACTH in treatment of infantile spasms
Infantile spasms (IS) is an age specific epileptic syndrome. With respect to poor response of IS to conventional anti-epileptic… 
2000
2000
Vigabatrina (Sabrilex) y defectos del campo visual
1999
1999
The new generation of anti-epileptic drugs
1. Summary Epilepsy is one of the most common neurological conditions, with an estimated prevalence of 50 m people worldwide… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)